Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition-Reference-Cited by-同舟云学术

Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition

Published:2021-05 Issue:6 Volume:1868 Page:119016
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Wang Cheng-Yi,Lee Meng-Hsuan,Kao Yu-Rung,Hsiao Shih-Hsin,Hong Shiao-Ya,Wu Cheng-Wen

Funder

Taiwan Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference53 articles.

1. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors;Singh;Drug Discov. Today,2018

2. P.R. Halliday, C.M. Blakely, T.G. Bivona, Emerging targeted therapies for the treatment of non-small cell lung cancer, Curr. Oncol. Rep., 21 (2019) 21.

3. Mechanisms of acquired resistance to tyrosine kinase inhibitors;Chen;Acta Pharm. Sin. B,2011

4. Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro;Nishino;Lung Cancer,2018

5. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation;Takezawa;Cancer Discov,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm;International Journal of Molecular Sciences;2024-05-12

2. E-cadherin re-expression: Its potential in combating TRAIL resistance and reversing epithelial-to-mesenchymal transition;Gene;2024-05

3. AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription;Heliyon;2024-04

4. Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilities;Cancer Letters;2024-03

5. Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review;Translational Lung Cancer Research;2024-02